Other clinical trials in people with non-Hodgkin's lymphoma [24] and sufferers with Superior malignancy [fourteen] have shown also that zosuquidar did not considerably have an affect on the pharmacokinetics of doxorubicin and had reasonable consequences about the pharmacokinetics of vincristine. These scientific trials permitted that zosuquidar could safely and securely https://hallaja221mxh4.elbloglibre.com/profile